Access cutting-edge neonatal opioid withdrawal syndrome treatment through this clinical trial at a research site in Hershey. Study-provided care at no cost to qualified participants.
Quick Self-Assessment
See if you qualify for this Hershey location
Preparing your pre-screening questions…
Access neonatal opioid withdrawal syndrome specialists at no cost
This study follows strict safety protocols and ethical guidelines
All study-related neonatal opioid withdrawal syndrome treatment provided free
Check if you qualify for this neonatal opioid withdrawal syndrome clinical trial in Hershey, PA
No-Cost Study Care
Local to Hershey
Convenient for PA residents
Cutting-Edge Treatment
Access to innovative therapies
Expert Medical Care
Close monitoring by specialists
Possible Compensation*
For time and travel
*Compensation varies by study. Confirm details with coordinator.
Infants with neonatal abstinence syndrome (NAS) experience prolonged hospital stays and poor neurodevelopmental outcomes, in-part because of the lack of accurate, individualized, biologic assessments available to manage this increasingly common medical condition. The proposed study will define the molecular mechanisms that regulate the response to opioid withdrawal in the developing brain by focusing on three candidate microRNAs (let-7a, miR-146a, miR-192) that have been shown to respond to opioid exposure in animal models and adults, and are impacted in both my preliminary study of infants with NAS, and my human neural progenitor cell (NPC) design of opioid withdrawal. By determining the mechanism through which microRNAs impact NPC differentiation in opioid withdrawal, and determining whether exosomal salivary microRNA levels predict treatment dose and neurodevelopmental outcomes in infants with NAS, this study will enhance our knowledge of NAS-related biology and identify potential biomarkers that could improve medical care for this important medical condition.
Sponsor: Milton S. Hershey Medical Center
Yes, this clinical trial (NCT05937594) has an active research site in Hershey, PA that is currently enrolling participants.
Clinical trials follow strict safety guidelines and ethical standards. This study has been reviewed and approved, and participants are closely monitored by medical professionals. You can withdraw at any time.
Many clinical trials offer compensation for your time and travel expenses. Specific compensation details will be discussed during the screening process. All study-related medical care is provided at no cost.
Absolutely. Participation is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty.
If you're searching for neonatal opioid withdrawal syndrome treatment options in Hershey, PA, this clinical trial (NCT05937594) may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Hershey research site is actively enrolling participants for this clinical trial. You'll receive care from experienced neonatal opioid withdrawal syndrome specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.
Looking for more options? Browse all neonatal opioid withdrawal syndrome clinical trials near you to find additional studies recruiting in your area.
See all huntingtons disease clinical trials recruiting in Hershey — not just this study.
Browse Huntingtons Disease Trials in Hershey →